These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 13802058)

  • 21. Oral calcium disodium versenate in treatment of lead poisoning.
    WILLIAMS JD; MATTHEWS GA; JUDD AW
    Br J Ind Med; 1962 Jul; 19(3):211-5. PubMed ID: 14007184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Our experiences with edathamil calcium disodium E.D.T.A. (mosatil-Bayer) in chronic lead exposure].
    SAVIOEVIC M; PETROVIC L; STANKOVIC M; DJORDJEVIC S
    Zentralbl Arbeitsmed; 1959 Jan; 9(1):6-12. PubMed ID: 13648734
    [No Abstract]   [Full Text] [Related]  

  • 23. [Problem of the therapy of chronic lead poisoning with ethylenediamine tetraacetic acid calcium disodium].
    SRBOVA J; TEISINGER J
    Arch Gewerbepathol Gewerbehyg; 1956; 14(6):579-93. PubMed ID: 13355405
    [No Abstract]   [Full Text] [Related]  

  • 24. [Lead poisoning and detoxication by calcium disodium edathamil; new observations].
    ALBAHARY C; TRUHAUT R; BOUDENE C
    Arch Mal Prof; 1957; 18(1):40-6. PubMed ID: 13412247
    [No Abstract]   [Full Text] [Related]  

  • 25. Lead nephropathy, gout, and hypertension.
    Batuman V
    Am J Med Sci; 1993 Apr; 305(4):241-7. PubMed ID: 8475950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CHRONIC LEAD NEPHROPATHY: THE DIAGNOSTIC USE OF CALCIUM EDTA AND THE ASSOCIATION WITH GOUT.
    EMMERSON BT
    Australas Ann Med; 1963 Nov; 12():310-24. PubMed ID: 14078907
    [No Abstract]   [Full Text] [Related]  

  • 27. [Oral treatment of saturnism with calcium versenate. Clinical and experimental study].
    CALABRESE A; ASTOLFI E; MARIANI F
    Dia Med; 1961 Oct; 33():2292-4. PubMed ID: 13875641
    [No Abstract]   [Full Text] [Related]  

  • 28. [Our experience with the prevention and therapy of lead poisoning with calcium disodium EDTA].
    HUZL F; SUCHANOVA L; SYKORA J
    Acta Univ Carol Med (Praha); 1961; Suppl 15():199-209. PubMed ID: 14036468
    [No Abstract]   [Full Text] [Related]  

  • 29. [Metabolic study of the effects of edathamil calcium in latent saturnism].
    VERBANCK M; TOUSSAINT C; TOPPET N; BASTENIER H; DESLYPERE P; DEGRAEF-MILLET
    Arch Mal Prof; 1959; 20(1):21-33. PubMed ID: 13628325
    [No Abstract]   [Full Text] [Related]  

  • 30. [CaEDTA in treatment of chronic lead poisoning].
    HSUEH HL
    Zhonghua Nei Ke Za Zhi; 1959 Mar; 7(3):212-9; English abstract 19. PubMed ID: 13652288
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of the CaNa2 EDTA Pb-mobilization test to detect occult lead nephropathy.
    Wedeen RP
    Uremia Invest; 1985-1986; 9(2):127-30. PubMed ID: 3939486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of intravenous calcium disodium versenate and oral penicillamine in promoting elimination of lead.
    HARRIS CE
    Can Med Assoc J; 1958 Oct; 79(8):664-6. PubMed ID: 13585293
    [No Abstract]   [Full Text] [Related]  

  • 33. Calcium versenate in the diagnosis of chronic lead nephropathy.
    EMMERSON BT; THIELE BR
    Med J Aust; 1960 Feb; 47(1)():243-8. PubMed ID: 13820202
    [No Abstract]   [Full Text] [Related]  

  • 34. [Alimentary lead poisoning caused by vinegar cruet screw cap; remarkable effect of a detoxicant: calcium disodium versenate (calcium EDTA)].
    ALBAHARY C; BOUDENE C
    Sem Hop; 1957 Mar; 33(14):912-6. PubMed ID: 13432850
    [No Abstract]   [Full Text] [Related]  

  • 35. [The use of chelating agents in the treatment of lead poisoning].
    de TAVARES JF; PORTO AL
    J Med (Oporto); 1961 Apr; 44():925-9. PubMed ID: 13775519
    [No Abstract]   [Full Text] [Related]  

  • 36. [Chelating agents in lead poisoning].
    ROCHE L; BADINAND A; LEJEUNE E
    Arch Mal Prof; 1960; 21():1-12. PubMed ID: 14438083
    [No Abstract]   [Full Text] [Related]  

  • 37. The treatment of tetraethyl lead poisoning.
    BOYD PR; HENDERSON IN; WALKER G
    Lancet; 1957 Jan; 272(6961):181-5. PubMed ID: 13399160
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical experience with the use of calcium disodium ethylenediaminetetraacetate in the therapy of lead poisoning.
    HARDY HL
    Fed Proc; 1961 Sep; 20(3)Pt 2():199-202. PubMed ID: 13904651
    [No Abstract]   [Full Text] [Related]  

  • 39. Lead nephropathy.
    Wedeen RP; D'Haese P; Van de Vyver FL; Verpooten GA; De Broe ME
    Am J Kidney Dis; 1986 Nov; 8(5):380-3. PubMed ID: 3098095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A contribution to the lead fuel problem].
    FATZER R
    Praxis; 1960 Apr; 49():350-2. PubMed ID: 13821698
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.